Publications by authors named "James Baker-Knight"

Claim this Profile
T
The out-of-pocket cost of living with obesity: Results from a survey in Spain, South Korea, Brazil, India, Italy, and Japan.
Karine Ferreira, Evant Kont, Amira Abdelkhalik, Dominic Jones, James Baker-Knight

Obes Sci Pract· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing economic investment required to scale up bariatric surgery capacity in England: a health economic modelling analysis.
James Baker-Knight, Dimitri J Pournaras, Kamal Mahawar, Richard Welbourn, Yuxin Li

BMJ Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the health and economic burden of obesity-related complications in East-Asian populations: implementation of risk equations in the Core Obesity Model for Japan and model validation.
Ichiro Tatsuno, Laetitia Gerlier, Anamaria-Vera Olivieri, James Baker-Knight, Mark Lamotte

BMJ Public Health· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of once-weekly subcutaneous semaglutide 2.4 mg on weight- and health-related quality of life in an East Asian population: Patient-reported outcomes from the STEP 6 trial.
Ronette L Kolotkin, Ole Kleist Jeppesen, James Baker-Knight, Sang Yeoup Lee, Asako Tokita

Clin Obes· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of BMI and comorbidities on efficacy of once-weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial.
Barbara M McGowan, Azadeh Houshmand-Oeregaard, Peter Nørkjaer Laursen, Niels Zeuthen, James Baker-Knight

Obesity (Silver Spring)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China.
Phil McEwan, James Baker-Knight, Björg Ásbjörnsdóttir, Yunni Yi, Aimee Fox

Eur J Health Econ· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The public economic burden of suboptimal type 2 diabetes control upon taxpayers in Sweden: Looking beyond health costs.
Nikolaos Kotsopoulos, Mark P Connolly, Michael Willis, Andreas Nilsson, Åsa Ericsson, James Baker-Knight

Diabetes Obes Metab· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Indirect Treatment Comparison of Semaglutide 2.0 mg vs Dulaglutide 3.0 mg and 4.5 mg Using Multilevel Network Meta-regression.
Ildiko Lingvay, Robert Bauer, James Baker-Knight, Jack Lawson, Richard Pratley

J Clin Endocrinol Metab· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Empagliflozin 25 mg for Treatment of Patients with Type 2 Diabetes in the UK Setting.
Matthew Capehorn, Nino Hallén, James Baker-Knight, Divina Glah, Barnaby Hunt

Diabetes Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Economic Burden of Insulin-Related Hypoglycemia in Adults with Diabetes: An Analysis from the Perspective of the Italian Healthcare System.
Witesh Parekh, Sophie E Streeton, James Baker-Knight, Roberta Montagnoli, Paolo Nicoziani

Diabetes Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: The Economic Burden of Insulin-Related Hypoglycemia in Spain.
Witesh Parekh, Nicki Hoskins, James Baker-Knight, Antonio Ramirez de Arellano, Pedro Mezquita Raya

Diabetes Ther· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Economic Burden of Insulin-Related Hypoglycemia in Spain.
Witesh Parekh, Nicki Hoskins, James Baker-Knight, Antonio Ramirez de Arellano, Pedro Mezquita Raya

Diabetes Ther· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis